Pricing Log in Create free account

GeoVax Labs Inc. (GOVX) vs VivoSim Labs, Inc. (VIVS)

GeoVax Labs Inc. and VivoSim Labs, Inc. are both Biotechnology companies. GeoVax Labs Inc. and VivoSim Labs, Inc. are of similar size ($2.8M and $2.6M). GeoVax Labs Inc. grew revenue faster over the last twelve months: 963.6% against −21.1%. GeoVax Labs Inc. has the higher net margin (0.00% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, GeoVax Labs Inc. leads on 9 and VivoSim Labs, Inc. on 6.

Valuation

Metric GOVX VIVS Biotechnology median
P/E n/m n/m 8.50
P/S 0.17 7.48 9.71
P/B 0.60 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.08 0.07 0.64
EV/Sales (0.27) (7.42) 9.21
Earnings yield (2,610.83%) (2,793.75%) (33.15%)
Free cash flow yield (1,752.21%) (143.87%) (25.50%)

Profitability

Metric GOVX VIVS Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (10,116.96%) 0.00%
Net margin 0.00% (11,016.07%) 0.00%
Free cash flow margin 0.00% (1,014.29%) 0.00%
Return on equity (891.59%) (343.10%) (56.36%)
Return on assets (408.79%) (155.93%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOVX VIVS Biotechnology median
Revenue growth (TTM) 963.56% (21.13%) 6.02%
EPS growth (last fiscal year) 81.41% (214.71%) 30.26%
Revenue growth, 5-year CAGR 16.18% (43.10%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOVX VIVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 1.70 4.72
Net debt to EBITDA 0.14 0.45 0.96

Dividend

Metric GOVX VIVS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOVX VIVS Biotechnology median
Market cap 2.61m 2.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack